Frontiers | External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinoma

by Hamamoto, Shuzo, Tasaki, Yoshihiko, Yamashita, Shimpei, Furukawa, Junya, Fujita, Kazutoshi, Tomida, Ryotaro, Makito, Miyake, Ito, Noriyuki, Iwamoto, Hideto, Sugiyama, Yosuke, Taguchi, Kazumi & Yasui, Takahiro | Aug 8, 2024 | Articles | 0 Comments